Page last updated: 2024-12-09

ebericol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ebericol: RN given refers to the unlabeled compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

eburicol : A tetracyclic triterpenoid that is 24,25-dihydrolanosterol carrying an additional methylene substituent at position 24. A natural product found in Taiwanofungus camphoratus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9803310
CHEMBL ID1644796
CHEBI ID70315
SCHEMBL ID4169147
MeSH IDM0063068

Synonyms (26)

Synonym
ebericol
eburicol
4,4,10,13,14-pentamethyl-17-(6-methyl-5-methylideneheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
6890-88-6
24-methylene-24,25-dihydrolanosterol
obtusifoldienol
24-methylenelanost-8-en-3beta-ol
24-methylidenelanost-8-en-3beta-ol
24-methylene-24-dihydrolanosterol
CHEBI:70315 ,
(3beta)-24-methylidenelanost-8-en-3-ol
SCHEMBL4169147
lanost-8-en-3-ol, 24-methylene-, (3.beta.)-
24-methylenelanost-8-en-3-ol #
lanost-8-en-3.beta.-ol, 24-methylene-
24-methylenedihydrolanosterol
XJLZCPIILZRCPS-ANMPWZFDSA-N
24-methylenelanostenol
4,4,14alpha-trimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol
Q27138657
(3s,5r,10s,13r,14r,17r)-4,4,10,13,14-pentamethyl-17-[(2r)-6-methyl-5-methylideneheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
MS-27926
CHEMBL1644796
DTXSID401319161
HY-123081
CS-0081164
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
tetracyclic triterpenoidAny triterpenoid consisting of a tetracyclic skeleton.
14alpha-methyl steroidAny steroid carrying a 14alpha-methyl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1527143Binding affinity to human CYP51 T314I mutant expressed in Escherichia coli assessed as decrease in demethylation incubated for 1 min2019Journal of medicinal chemistry, 11-27, Volume: 62, Issue:22
Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.11)18.7374
1990's7 (38.89)18.2507
2000's2 (11.11)29.6817
2010's7 (38.89)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]